Banco Macro Valuation
Is BMA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BMA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BMA (ARS8960) is trading above our estimate of fair value (ARS4533.06)
Significantly Below Fair Value: BMA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BMA?
Key metric: As BMA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is BMA's PE Ratio? | |
|---|---|
| PE Ratio | 12.2x |
| Earnings | AR$471.29b |
| Market Cap | AR$5.72t |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.3x |
Price to Earnings Ratio vs Peers
How does BMA's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 17.1x | ||
GGAL Grupo Financiero Galicia | 11.7x | 8.4% | AR$9.3t |
BBAR Banco BBVA Argentina | 27.2x | 22.2% | AR$3.7t |
BPAT Banco Patagonia | 16.8x | n/a | AR$1.6t |
BHIP Banco Hipotecario | 12.9x | n/a | AR$690.9b |
BMA Banco Macro | 12.2x | 36.8% | AR$5.7t |
Price-To-Earnings vs Peers: BMA is good value based on its Price-To-Earnings Ratio (12.2x) compared to the peer average (17.1x).
Price to Earnings Ratio vs Industry
How does BMA's PE Ratio compare vs other companies in the South American Banks Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: BMA is expensive based on its Price-To-Earnings Ratio (12.2x) compared to the South American Banks industry average (8.7x).
Price to Earnings Ratio vs Fair Ratio
What is BMA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 12.2x |
| Fair PE Ratio | 18.3x |
Price-To-Earnings vs Fair Ratio: BMA is good value based on its Price-To-Earnings Ratio (12.2x) compared to the estimated Fair Price-To-Earnings Ratio (18.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | AR$8,960.00 | AR$12,202.82 +36.2% | 32.7% | AR$17,860.00 | AR$7,930.00 | n/a | 5 |
| Nov ’25 | AR$8,890.00 | AR$12,878.53 +44.9% | 32.6% | AR$17,860.00 | AR$7,930.00 | n/a | 4 |
| Oct ’25 | AR$8,100.00 | AR$28,870.50 +256.4% | 115.5% | AR$95,034.37 | AR$6,908.00 | n/a | 5 |
| Sep ’25 | AR$7,610.00 | AR$10,564.88 +38.8% | 36.0% | AR$17,860.00 | AR$6,908.00 | n/a | 5 |
| Aug ’25 | AR$6,460.00 | AR$10,191.08 +57.8% | 40.0% | AR$17,860.00 | AR$6,560.00 | n/a | 5 |
| Jul ’25 | AR$7,224.60 | AR$10,191.08 +41.1% | 40.0% | AR$17,860.00 | AR$6,560.00 | n/a | 5 |
| Jun ’25 | AR$8,327.50 | AR$9,491.08 +14.0% | 46.6% | AR$17,860.00 | AR$6,000.00 | n/a | 5 |
| May ’25 | AR$5,936.90 | AR$5,500.88 -7.3% | 48.6% | AR$10,127.41 | AR$2,256.00 | n/a | 5 |
| Apr ’25 | AR$5,571.35 | AR$3,583.20 -35.7% | 43.5% | AR$6,000.00 | AR$1,620.00 | n/a | 5 |
| Mar ’25 | AR$4,210.65 | AR$2,963.20 -29.6% | 33.3% | AR$4,420.00 | AR$1,620.00 | n/a | 5 |
| Feb ’25 | AR$4,444.00 | AR$2,805.00 -36.9% | 43.6% | AR$4,420.00 | AR$829.00 | n/a | 5 |
| Jan ’25 | AR$2,670.00 | AR$2,053.86 -23.1% | 50.6% | AR$3,620.00 | AR$829.00 | n/a | 5 |
| Dec ’24 | AR$2,633.80 | AR$2,026.86 -23.0% | 51.9% | AR$3,620.00 | AR$829.00 | n/a | 5 |
| Nov ’24 | AR$1,687.50 | AR$1,988.90 +17.9% | 48.3% | AR$3,620.00 | AR$829.00 | AR$8,890.00 | 5 |
| Oct ’24 | AR$1,467.55 | AR$1,599.70 +9.0% | 44.2% | AR$2,415.00 | AR$368.00 | AR$8,100.00 | 5 |
| Sep ’24 | AR$2,047.45 | AR$1,599.70 -21.9% | 44.2% | AR$2,415.00 | AR$368.00 | AR$7,610.00 | 5 |
| Aug ’24 | AR$1,444.65 | AR$982.13 -32.0% | 67.8% | AR$1,660.50 | AR$311.00 | AR$6,460.00 | 4 |
| Jul ’24 | AR$1,432.15 | AR$982.13 -31.4% | 67.8% | AR$1,660.50 | AR$311.00 | AR$7,224.60 | 4 |
| Jun ’24 | AR$910.85 | AR$780.88 -14.3% | 70.4% | AR$1,660.50 | AR$311.00 | AR$8,327.50 | 4 |
| May ’24 | AR$806.90 | AR$677.30 -16.1% | 78.7% | AR$1,660.50 | AR$269.00 | AR$5,936.90 | 5 |
| Apr ’24 | AR$720.75 | AR$677.30 -6.0% | 78.7% | AR$1,660.50 | AR$269.00 | AR$5,571.35 | 5 |
| Mar ’24 | AR$760.00 | AR$682.50 -10.2% | 78.4% | AR$1,660.50 | AR$269.00 | AR$4,210.65 | 5 |
| Feb ’24 | AR$789.65 | AR$675.50 -14.5% | 80.0% | AR$1,660.50 | AR$234.00 | AR$4,444.00 | 5 |
| Jan ’24 | AR$561.10 | AR$598.30 +6.6% | 89.7% | AR$1,660.50 | AR$234.00 | AR$2,670.00 | 5 |
| Dec ’23 | AR$461.80 | AR$446.60 -3.3% | 53.8% | AR$902.00 | AR$234.00 | AR$2,633.80 | 5 |
| Nov ’23 | AR$471.80 | AR$445.00 -5.7% | 54.3% | AR$902.00 | AR$226.00 | AR$1,687.50 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Lloyds Banking Group
UK£34.2b
Provides a range of banking and financial services in the United Kingdom and internationally.
LYG
UK£1,625.00
7D
-0.3%
1Y
71.7%
Grupo Financiero Galicia
AR$9.3t
A financial service holding company, provides various financial products and services to individuals and companies in Argentina.
GGALD
AR$5.76
7D
2.7%
1Y
300.0%
Banco Santander (Brasil)
R$95.9b
Provides various banking products and services to individuals, small and medium enterprises, and corporate customers in Brazil and internationally.
BSBR
R$5,060.00
7D
-5.9%
1Y
-8.7%